Prime Medicine, Inc.

NASDAQ:PRME

Biotechnology

Healthcare
$3.84 -1.11%

-$0.04 today

Market cap
$698.58M
Beta
2.31
P/E (TTM)
-2.8
EPS (TTM)
-$1.12
52W Low $1.77High $6.94

Volume 3.99M

Average 2.47M

Income Statement

Follow revenue through to earnings.

Revenue

$4.63M

FY 2025 · Annual

+55.3% YoY

Operating Income

-$208.35M

FY 2025 · Annual

Net Income

-$201.14M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0002.98M4.63M
Cost of Revenue00007.32M
Gross Profit0002.98M(2.69M)
Gross Margin———100.0%-58.1%
Research & Development70.55M86.73M147.91M155.29M160.64M
Selling, General & Admin13.92M29.82M43.39M50.16M52.35M
Operating Expenses84.47M116.54M204.79M205.45M205.66M
Depreciation & Amortization568K2.22M4.65M6.13M5.38M
EBITDA(165.29M)(120.55M)(186.64M)(189.75M)(195.76M)
EBITDA Margin———-6361.2%-4226.2%
Operating Income(84.47M)(116.54M)(204.79M)(202.47M)(208.35M)
Operating Margin———-6787.4%-4498.1%
Interest Income0003.52M4.15M
Interest Expense00000
Other Income / Expenses(81.38M)(6.23M)6.38M6.59M7.21M
Income Before Tax(165.85M)(122.77M)(198.41M)(195.88M)(201.14M)
Pre-Tax Margin———-6566.6%-4342.4%
Income Tax Expense(486K)(948K)(279K)00
Net Income(165.37M)(121.82M)(198.13M)(195.88M)(201.14M)
Net Margin———-6566.6%-4342.4%
EPS (Basic)(1.92)(1.46)(2.18)(1.65)(1.35)
EPS (Diluted)(1.92)(1.46)(2.18)(1.65)(1.35)
Weighted Avg Shares95.73M97.21M90.97M118.6M148.76M
Weighted Avg Shares (Diluted)95.73M97.21M90.97M118.6M148.76M

PRME Earnings Waterfall · TTM

NASDAQ:PRME · Revenue to Net Income

Key Ratios

EPS$-1.27
Gross Margin-893.8%
Net Margin-5020.8%
P/E Ratio-3.0
P/S Ratio587.0

Analysis

$4.0M of revenue converted into -$198.4M of net income for the selected period. Gross margin is -893.8% and net margin is -5020.8%, showing how much revenue survives after costs and taxes. EPS is $-1.27, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 13, 2026
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
8-KCurrent reportNov 12, 2026

How much revenue does PRME generate?

Prime Medicine, Inc. (PRME) reported $4.63M of revenue in fiscal 2025.

Is PRME profitable?

Prime Medicine, Inc. (PRME) reported -$201.14M of net income, with a net margin of -4342.4%.